Issuer

Big Pharma Split Corp.

Split Shares & Funds

Some content is not available to unregistered visitors. Please

click here to login or register a free account.

Related Documents
Rating Reports1
Press Releases8
Research0
Regulatory8
November 24, 2017
Big Pharma Split Corp.: Rating Report
1 / 1

dbrs.morningstar.com Privacy Statement
By accessing this website you agree to be bound by the Morningstar DBRS Terms and Conditions and also the Privacy Policy. These are subject to change. Any changes will be incorporated into the Terms and Conditions or Privacy Policy posted to this website from time to time.

Big Pharma Split Corp.

Related Documents
Rating Reports1
Press Releases8
Research0
Regulatory8
November 24, 2017
Big Pharma Split Corp.: Rating Report
1 / 1

Big Pharma Split Corp.: Rating Report

Contacts

Strong Earnings in H1 2024 Continue to Support Positive Outlook on Global P&C Reinsurers

SRTs: Another Tool in the Toolkit as Large Canadian Banks Increasingly Look to Manage Capital and Risk

UK Servicers Do Their (Consumer) Duty

Surplus Notes Remain an Attractive Source of Statutory Capital For U.S. Insurers

Big Pharma Split Corp.

Related DocumentsRating Reports1Press Releases8Research0Regulatory8November 24, 2017Big Pharma Split Corp.: Rating Report1 / 1

Big Pharma Split Corp.: Rating Report

Contacts

More from Morningstar DBRS

Strong Earnings in H1 2024 Continue to Support Positive Outlook on Global P&C Reinsurers

SRTs: Another Tool in the Toolkit as Large Canadian Banks Increasingly Look to Manage Capital and Risk

UK Servicers Do Their (Consumer) Duty

Surplus Notes Remain an Attractive Source of Statutory Capital For U.S. Insurers

Related Events

Related Documents
Rating Reports1
Press Releases8
Research0
Regulatory8
November 24, 2017
Big Pharma Split Corp.: Rating Report
1 / 1